JP2007507425A5 - - Google Patents

Download PDF

Info

Publication number
JP2007507425A5
JP2007507425A5 JP2006524933A JP2006524933A JP2007507425A5 JP 2007507425 A5 JP2007507425 A5 JP 2007507425A5 JP 2006524933 A JP2006524933 A JP 2006524933A JP 2006524933 A JP2006524933 A JP 2006524933A JP 2007507425 A5 JP2007507425 A5 JP 2007507425A5
Authority
JP
Japan
Prior art keywords
group
solvate
hydrate
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006524933A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007507425A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/028115 external-priority patent/WO2005021040A2/en
Publication of JP2007507425A publication Critical patent/JP2007507425A/ja
Publication of JP2007507425A5 publication Critical patent/JP2007507425A5/ja
Pending legal-status Critical Current

Links

JP2006524933A 2003-08-29 2004-08-27 胃腸管運動障害を処置するために有用な組成物 Pending JP2007507425A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49920003P 2003-08-29 2003-08-29
US59823504P 2004-08-03 2004-08-03
PCT/US2004/028115 WO2005021040A2 (en) 2003-08-29 2004-08-27 Compositions useful for treating gastrointestinal motility disorders

Publications (2)

Publication Number Publication Date
JP2007507425A JP2007507425A (ja) 2007-03-29
JP2007507425A5 true JP2007507425A5 (https=) 2007-10-18

Family

ID=34278649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006524933A Pending JP2007507425A (ja) 2003-08-29 2004-08-27 胃腸管運動障害を処置するために有用な組成物

Country Status (10)

Country Link
US (3) US20050059704A1 (https=)
EP (1) EP1663313A2 (https=)
JP (1) JP2007507425A (https=)
KR (1) KR20060118421A (https=)
AU (2) AU2004268641A1 (https=)
BR (1) BRPI0414046A (https=)
CA (1) CA2537182A1 (https=)
IL (1) IL173835A0 (https=)
MX (1) MXPA06002139A (https=)
WO (1) WO2005021040A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060118421A (ko) * 2003-08-29 2006-11-23 다이노젠 파마세우티컬스, 인코포레이티드 위장 운동 장애의 치료에 유용한 조성물
KR20060099524A (ko) * 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체
US20070010543A1 (en) * 2005-07-01 2007-01-11 Dynogen Pharmaceuticals, Inc. Compositions and methods for treating gastrointestinal hypomotility and associated disorders
WO2008011016A2 (en) * 2006-07-18 2008-01-24 Dynogen Pharmaceuticals, Inc. Treating gastroesophageal reflux disease with 5-ht3- and gaba receptor agonists
CA2690581A1 (en) * 2007-06-07 2008-12-18 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastroesophageal reflux disease
KR101605063B1 (ko) * 2009-07-09 2016-03-21 라퀄리아 파마 인코포레이티드 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제
BR112013020641B1 (pt) * 2011-02-25 2021-11-03 Yuhan Corporation Composto, composição farmacêutica, processos para a preparação de composto e respectivo uso ou de seu sal farmaceuticamente aceitável
WO2020185857A1 (en) * 2019-03-12 2020-09-17 The Board Of Regents Of The University Of Texas System Simultaneous blood glucose monitoring and gastric emptying scintigraphy

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220011A3 (en) * 1985-10-12 1990-01-03 Beecham Group Plc Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
IE903747A1 (en) * 1989-10-19 1991-04-24 Searle & Co Method of treating gastrointestinal motility disorders
US5260303A (en) * 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
ES2109190B1 (es) * 1996-03-22 1998-07-01 Univ Madrid Complutense Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht
US6288234B1 (en) * 1998-06-08 2001-09-11 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
TR200100431T2 (tr) * 1998-08-10 2001-06-21 Partnership Of Michael E. Garst, George Sachs & Jai Moo Proton pompalama önleyici ilaçlar
US6436953B1 (en) * 1998-09-23 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
US6362202B1 (en) * 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) * 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
JP3354132B2 (ja) * 1999-06-15 2002-12-09 三共株式会社 光学活性なピロロピリダジン化合物
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease
JP4584534B2 (ja) * 2000-06-07 2010-11-24 アリックス セラピューティクス 胃食道逆流性疾患の治療のための材料
JP2004518709A (ja) * 2001-02-13 2004-06-24 アストラゼネカ・アクチエボラーグ 新規放出修飾製剤
SE0101379D0 (sv) * 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
MXPA03011096A (es) * 2001-05-29 2004-12-06 Depomed Dev Ltd Metodo para el tratamiento de la enfermedad de reflujo gastroesofagico y la saturacion acida nocturna.
EP1829543B1 (en) * 2001-08-24 2009-01-21 Mitsubishi Tanabe Pharma Corporation Preventive agent/remedial agent for constipation predominant IBS
US20060281682A1 (en) * 2003-01-28 2006-12-14 Currie Mark G Methods and compositions for the treatment of gastrointestinal disorders
WO2004105795A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
KR20060118421A (ko) * 2003-08-29 2006-11-23 다이노젠 파마세우티컬스, 인코포레이티드 위장 운동 장애의 치료에 유용한 조성물

Similar Documents

Publication Publication Date Title
KR102123365B1 (ko) 항박테리아 치료제 및 예방제
US20060241134A1 (en) Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
JP2011503103A5 (https=)
JP2009543860A5 (https=)
JP2011526926A5 (https=)
JP2007505877A5 (https=)
JP2005511531A5 (https=)
JP2009541223A5 (https=)
JP2013539789A5 (https=)
JP2009523760A5 (https=)
US12208097B2 (en) Protein kinase C inhibitors for treatment of uveal melanoma
JP2016534124A5 (https=)
JP2012515787A5 (https=)
JP2008534453A5 (https=)
SI1758853T1 (sl) Antagonisti glukagonskega receptorja priprava inuporaba v terapiji
JP2007500700A5 (https=)
RU2015121037A (ru) Производные фенилэтилпиридина в качестве ингибиторов pde-4
JP2007515476A5 (https=)
JP2010522218A5 (https=)
JP2007507425A5 (https=)
EA019037B1 (ru) 5-[5-[2-[3,5-бис(трифторметил)фенил-2-метилпропаноилметиламино]-4-(4-фтор-2-метилфенил)]-2-пиридинил]-2-алкилпролинамиды в качестве антагонистов рецептора nk1
US20220133888A1 (en) Combination of regorafenib and pd-1/pd-l1(2) inhibitors for treating cancer
JP2005513017A5 (https=)
US9540375B2 (en) Kappa opioid receptor effectors and uses thereof
JP2006500315A5 (https=)